arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Bausch & Lomb Corp

BLCO
$17.07 ▼ -0.27 (-1.53%) at close
Industrials ·Ophthalmic Goods ·USOphthalmic Goods
7 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
34
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bausch & Lomb Corp faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.0B
Dividend Yield —
Revenue Growth 6.5% ↘
Op. Margin 2.2% ↘
ROIC 1.1% ↘
FCF / Share $-0.19 ↘
Trailing P/E —
Price / Book 0.9x
FCF Yield —
Debt / Equity 0.78
info Valuation on last close. End-of-day price, Sep 23, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.10B
↑ +6.5% —
Net Income Profit after all expenses
$-360.00M
↓ -13.6% —
Operating Margin Operating profit as % of sales
2.2%
↓ -34.5% 34th
FCF / Share Free cash flow per share
$-0.19
↓ -11.2% —
Long-Term Debt Long-term obligations
$5.05B
↑ +5.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
25
Returns
38
Financial Health ↓
43
Cash Quality ↓
29

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 24 quarters